key: cord-0868654-ai8zzgpj
authors: Yao, Jin-Cao; Wang, Tao; Hou, Guang-Hua; Ou, Di; Li, Wei; Zhu, Qiao-Dan; Chen, Wen-Cong; Yang, Chen; Wang, Li-Jing; Wang, Li-Ping; Fan, Lin-Yin; Shi, Kai-Yuan; Zhang, Jie; Xu, Dong; Li, Ya-Qing
title: AI detection of mild COVID-19 pneumonia from chest CT scans
date: 2021-03-18
journal: Eur Radiol
DOI: 10.1007/s00330-021-07797-x
sha: 27b9432a4f25225e5301935e7c514a6af5340bd2
doc_id: 868654
cord_uid: ai8zzgpj

OBJECTIVES: An artificial intelligence model was adopted to identify mild COVID-19 pneumonia from computed tomography (CT) volumes, and its diagnostic performance was then evaluated. METHODS: In this retrospective multicenter study, an atrous convolution-based deep learning model was established for the computer-assisted diagnosis of mild COVID-19 pneumonia. The dataset included 2087 chest CT exams collected from four hospitals between 1 January 2019 and 31 May 2020. The true positive rate, true negative rate, receiver operating characteristic curve, area under the curve (AUC) and convolutional feature map were used to evaluate the model. RESULTS: The proposed deep learning model was trained on 1538 patients and tested on an independent testing cohort of 549 patients. The overall sensitivity was 91.5% (195/213; p < 0.001, 95% CI: 89.2–93.9%), the overall specificity was 90.5% (304/336; p < 0.001, 95% CI: 88.0–92.9%) and the general AUC value was 0.955 (p < 0.001). CONCLUSIONS: A deep learning model can accurately detect COVID-19 and serve as an important supplement to the COVID-19 reverse transcription–polymerase chain reaction (RT-PCR) test. KEY POINTS: • The implementation of a deep learning model to identify mild COVID-19 pneumonia was confirmed to be effective and feasible. • The strategy of using a binary code instead of the region of interest label to identify mild COVID-19 pneumonia was verified. • This AI model can assist in the early screening of COVID-19 without interfering with normal clinical examinations. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-021-07797-x.

Coronavirus disease 2019 (COVID- 19) can cause a fatal acute respiratory distress syndrome and has spread worldwide [1] [2] [3] [4] [5] . The main diagnostic methods for COVID-19 include the IgG/IgM antibody test, the reverse transcriptionpolymerase chain reaction (RT-PCR) test and a chest computed tomography (CT) exam [6] [7] [8] [9] . At present, the RT-PCR test has been used widely to screen COVID-19 close contacts and presumptive patients [6] . However, the RT-PCR test is not sufficiently sensitive [7] , and the test results are influenced by the experimental environment, kit quality and sampling skills in the actual examination [10] . Meanwhile, the limited supply of RT-PCR reagents has also brought about unprecedented challenges in preventing the spread of the disease.

Chest CT scans are a critical component in the diagnosis of suspected COVID-19 patients [6, [11] [12] [13] [14] [15] [16] . For example, Tao et al [6] analysed 1014 cases and demonstrated that the sensitivity of a chest CT exam was 88%. Another study of 51 COVID-19 patients showed that the chest CT scan identified 50 cases successfully [7] . Compared with the RT-PCR test, a chest CT scan provides more standard and intuitive information, and it could serve as an important supplement to the RT-PCR test [13, 16] . However, since there are a large number of COVID-19 close contacts who need to be scanned, expanding the use of chest CT for rapid scanning is likely to be constrained by a shortage of radiologists. Automatic analysis of chest CT images using a computer-assisted diagnosis (CAD) model is proposed as a solution to this issue [17] [18] [19] .

Recently, as one of the core artificial intelligence (AI) technologies, deep learning has achieved significant accuracy in automatic detection of many lung diseases [20] [21] [22] [23] [24] . Therefore, studies have begun to explore adopting a deep learning-based medical image analysis model to assist in the diagnosis of COVID-19 [25] [26] [27] [28] [29] , such as an AI-based COVID-19 detection model [25] and the EfficientNet B4 recognition model [26] , and these efforts have made certain progress.

However, the existing models still have shortcomings. First, the existing models for COVID-19 recognition require the extraction of the lung region [25] or suspicious slices [29] from the CT volume, thus greatly reducing the utility of the model. Second, for the severe or critical ill COVID-19 patients, the lesions are relatively obvious and easily recognised by the radiologists or CAD models. However, it has been reported that about 80% of the infected people were COVID-19 cases with mild pneumonia, and have only small lesions in the CT volumes [3] . The existing models have limited ability to detect and locate these small lesions [26, 29] . Third, in clinical examination, there are some mild COVID-19 pneumonia cases with CT findings for whom the initial RT-PCR results were negative. Whether a deep learning model can correctly identify these cases has not yet been reported. Due to the large proportion of the mild COVID-19 pneumonia cases in early screening, AI models which can accomplish the above tasks are needed urgently.

In this study, we developed a deep learning model to identify mild COVID-19 pneumonia. The model adopted the recent atrous convolution-based technology [30] [31] [32] [33] , which has a strong ability for detail feature extraction. By assigning simple binary labels, the proposed model can largely reduce the manual intervention needed and assist in the rapid screening of presumptive COVID-19 patients.

We used chest CT scans from four hospitals, and Table 1 shows the basic information of the hospitals and patients. The study was approved by the ethics committees of all the participating hospitals, and the data were analysed anonymously. The samples included 2946 3D volumetric chest CT exams from 2575 patients with a diagnosis of COVID-19 pneumonia, community-acquired pneumonia (CAP) and non-pneumonia (NP). All the data were collected between 1 January 2019 and 31 May 2020. The inclusion criteria were as follows: (1) CT volumes with a layer thickness ≤ 5 mm; (2) patients with clinical signs of mild pneumonia but no signs of severe pneumonia: SpO2 ≥ 90% on room air, have clinical symptoms (fever, cough, dyspnoea, fast breathing) and CT findings (small patchy shadow, interstitial changes, ground glass opacity and infiltration), or close contacts only have CT findings, and this inclusion criteria is only applicable to the COVID-19 and CAP cases [5] ; (3) NP and mild CAP patients treated before 1 December 2019 or NP, mild CAP and mild COVID-19 pneumonia patients after 1 December 2019 who had received an RT-PCR test; (4) patient's initial CT scan (repeated examinations were removed). After applying the inclusion criteria, 2087 chest CT scans remained, with each CT scan corresponding to a unique patient. In total, 568 (27%) were mild COVID-19 pneumonia cases, 763 (37%) 

The CT scans of all the enrolled patients were performed on CT scanners manufactured by the General Electric Company (GE) and Siemens. The patients were scanned in a head-first supine position with their arms raised and placed beside their ears. All of the patients underwent CT scanning without the administration of contrast material. The parameters of the CT scans were as follows: tube energy 120 kV; reference tube current 110-260 mAs; pitch 0.81-1.22 mm; each volume contained 93-564 slices with a varying slice thickness from 1 to 5 mm; median CTDI vol 2.9 mGy (IQR 1.8-4.2). To avoid center effect, all samples were reconstructed with the soft reconstruction kernel and 5 mm slice thickness, and the matrix was 512×512.

Instead of pre-extraction of lung shapes or suspicious slices to accomplish the identification task, our dataset was labelled in a binary fashion according to the following rules: samples that were both RT-PCR positive and CT imaging-conformed COVID-19 were labelled as 1; samples that were negative in RT-PCR testing or the cases that occurred before 30 November 2019 were labelled as 0. All identifying patient information was removed to protect privacy.

In previous work, by introducing sparse constrained atrous convolution to the traditional ResNet [31, 34] , we built a cross-layer sparse atrous convolution network (CSAC-Net) which performed well in official tests of pattern analysis, statistical modelling, computational learning and visual object classification (PASCAL VOC) dataset 1 . In the current study, we extended the above model to a three-dimensional version, thereby establishing a 3D CSAC-Net for the CT imagingbased diagnosis of COVID-19 cases with mild pneumonia. The overall structure of the proposed model is shown in Fig.  1 , and it included 39 layers of 3D convolution, 10 layers of 3D atrous convolution, 3 layers of 3D max pooling in baseline, 5 layers of 3D max pooling in cross-layer subnets and 3 layers of full connection. As is shown in Fig. 1 , a cross-layer 3D atrous convolution structure was designed between each two residual modules. The feature maps from the cross-layer subnets were merged into the output of baseline as the basis of full connection layer. Details of the parameter settings and equations for the network are shown in Supplementary Materials 2. Although we adopted three cross-layers in this paper, for larger-scale data, repeatedly increasing the number of this structure to seek better recognition performance could be considered. We also compared the performance of our 3D CSAC-Net with baseline 3D ResNet [34] , support vector machine (SVM) [35] and random forest (RF) [36] methods with common parameter settings (see Supplementary Materials 3).

All the 1538 (74%) patients from the first three centers were used to train the model, while the 549 (26%) patients from the fourth center were treated as the independent testing cohort to verify the performance. Image enhancement methods were used during training, including 0.9 to 1.1 times random scaling, horizontal reversal, vertical reversal and −15°to 15°random rotation. The size of the training batch was 10, the gradient descent strategy was based on an Adam optimiser and the initial learning rate was 10 −3 . The final model was trained for 75 epochs under the above super-parameters.

The trained deep learning model was evaluated with the 549patient independent testing set to assess its sensitivity and specificity in identification. We calculated the true positive rate and the true negative rate of the model with different thresholds and used the receiver operating characteristic (ROC) curve with a 95% confidence interval (CI) and the corresponding area under the curve (AUC) to evaluate the model's performance. Several typical COVID-19, CAP and NP samples were selected to generate heatmaps.

The software used to develop the DCNN model was based on the Ubuntu 16. 

The detailed distributions of the training set and independent testing set are shown in Table 2 . To better evaluate the model, we divided the independent testing set into three subsets. Subset S1 was the mild COVID-19 pneumonia cases, S2 was the NP cases and S3 was the mild CAP cases. The first panel in Fig. 2 shows the ROC curves for the three conditions. The black curve is the overall ROC curve for distinguishing mild COVID-19 pneumonia cases from the rest of the patients (S1 vs S2 + S3 Fig. 1 Graphical summary of the utilized deep learning method: (a) the training set and binary labels, (b) the general framework of the 3D CSAC-Net, (c) the testing set with new patients and the model output equals to 3.6 × 10 −4 which is less than 0.001, indicating no statistical difference. The ROC curve of the 3D-ResNet, RF and SVM methods is also shown in Fig. 2 . The results of the SVM method were slightly better than the RF method, and their respective AUCs were between 0.670 and 0.764, while the performance of deep learning methods was superior to that of traditional methods, with AUC values between 0.910 and 0.957. Table 3 compares the identification results of the AI model under different thresholds with two junior radiologists (less than 5 years of experience) and two senior radiologists (more than 10 years of experience). As was shown, the recognition performance of the AI model was better than that of manual interpretation, and the model achieved better performance when setting the threshold value to 0.5. Moreover, compared with the average 196 seconds for manual identification, the average processing time of our model for each chest CT volume in the test set was 0.66 s, indicating a high detection efficiency. We also calculated the sensitivity of detection of those COVID-19 cases which obtained a negative result in the initial RT-PCR test. Figure 3 shows slices of the original chest CT images and the corresponding heatmaps, and these heatmaps were extracted from the last 3D max pooling layer. Figure 3a to c are the original chest CT slices of the COVID-19 patients. The model recognised mild COVID-19 pneumonia accurately, and many high-weight features were extracted from the lesion areas ( Fig.  3d to f) . For non-COVID-19 patients, the weights of the feature maps (Fig. 3j to l) were significantly lower, even when some lesions were present. Figure 4 shows several typical misdiagnosed samples. Figure 4a is a misdiagnosed COVID-19 case, and Fig. 4b and c are typical mild CAP patients that were misidentified as COVID-19. As can be seen, these samples were challenging, and by analysing the corresponding heatmaps, we believe that the misdiagnoses of COVID-19 were mainly due to the insignificant lesions, while the false positive sample was caused by the great similarity in convolutional features.

An effective AI model, 3D CSAC-Net, was developed to identify mild COVID-19 pneumonia and mark the corresponding lesion areas. To the best of our knowledge, this is the first multi-center study that has adopted an AI model which does not require pre-extraction of ROI or suspicious slices to identify mild COVID-19 pneumonia. And it is also the first report on the use of AI to identify mild COVID-19 pneumonia cases with negative results in initial RT-PCR. The experimental results using the independent testing set showed a sensitivity, specificity and AUC value of 91.5%, 90.5% and 0.955, respectively. Since the RT-PCR test is not sufficiently sensitive, using AI to process CT images to screen close contacts or presumptive patients would be an important supplement.

At present, AI models that can accurately detect COVID-19 are urgently needed, and the following problems need to be taken into account: (1) compared with the critical ill COVID-19 patients whose lesions are obvious in chest CT scans and relatively easy to diagnose through IgG/IgM testing [37, 38] , most of the infected people have only small lesions in the CT volumes [3, 39] , so it is necessary to develop AI models which can accurately identify these small lesions in the early screen; (2) complex pre-processing and manual interventions need to be reduced as much as possible to increase the usability of the model; and (3) in addition to recognising the COVID- 19 cases, the feature heatmaps of the AI model should locate the lesions. However, the previous models have limited ability to solve these problems, and the recognition bias is more obvious when the lesions are small (see Fig. 3 in [25] , Fig. 5 in [26] and Fig. 4 in [29] ). Recently, many efforts have been devoted to these problems [40] [41] [42] [43] . And in this study, to address the first and second issues listed above, we designed a 3D deep learning model that uses the simple binary labels to identify mild COVID-19 pneumonia and greatly reduces the manual intervention. The labels are used in the training stage only, and the normalised CT images can be input into the model directly in practical application. To address the third issue, our proposed model uses the recent atrous convolution method, which has superior detailed feature extraction abilities (see Fig. 3d -f), and that is of great help to radiologists. There are still some limitations to this study. First, although all the cases of COVID-19 included in the study were confirmed via RT-PCR testing, the CAP and NP patient samples from before 30 November 2019 were not tested by RT-PCR. Considering that the virus outbreak was first detected in December 2019, we treated the CAP and NP patients prior to 30 November 2019 as non-COVID-19 patients by default. Second, due to the self-learning and black box properties of deep learning itself, the specific connotations of high-weight regions of convolutional feature maps still need to be explored. Third, to reduce the complexity of integrating the model into computer-assisted diagnostic systems or remote diagnostic systems, our study did not identify the category of CAP. Since many AI models have been proposed to identify different types of CAP [44, 45] , we plan to combine our deep learning network with CAP recognition methods and optimise our model further in the future. Fourth, in this study, we reconstructed all data to uniform 5 mm slice thickness to reduce center effect. However, the center effect could not be completely avoided, especially when compared with other models, because these models might be trained and tested on completely different data sets.

In summary, a deep learning model based on atrous convolution was designed to identify mild COVID-19 pneumonia and mark the corresponding lesion areas. A total of 2087 chest CT scans from four hospitals were studied. The experimental results showed that both the sensitivity and specificity were greater than 90%, and the general AUC value was 0.955, indicating clinical applicability. The comparative study also have shown that the performance of our model was superior to the identification of traditional methods and radiologists, especially for those mild COVID-19 pneumonia cases which obtained negative results in the initial RT-PCR test. The proposed model is expected to be an efficient and economic method for assisting in the early screening of COVID-19 without interfering in normal clinical examinations.

The online version contains supplementary material available at https://doi.org/10.1007/s00330-021-07797-x.

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Structural basis of receptor recognition by SARS-CoV-2

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese center for disease control and prevention

Effective containment explains subexponential growth in recent confirmed COVID-19 cases in China

Clinical management of COVID-19 interim guidance

Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases

Sensitivity of chest CT for COVID-19: comparison to RT-PCR

Diagnostic performance of immunochromatography assay for rapid detection of IgM and IgG in coronavirus disease 2019

Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China

Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: a descriptive study

Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection

Outbreak of novel coronavirus (COVID-19): what is the role of radiologists?

Characteristic CT findings distinguishing 2019 novel coronavirus disease (COVID-19) from influenza pneumonia

A novel coronavirus from patients with pneumonia in China

Chest computed tomography findings of coronavirus disease 2019 (COVID-19) pneumonia

CT features of novel coronavirus pneumonia (COVID-19) in children

Using artificial intelligence to detect COVID-19 and community-acquired pneumonia based on pulmonary CT: evaluation of the diagnostic accuracy

Inf-Net: automatic COVID-19 lung infection segmentation from CT images

Automated assessment of COVID-19 pulmonary disease severity on chest radiographs using convolutional Siamese neural networks

Development and validation of a deep learning model for non-small cell lung cancer survival

Deep convolutional neural network-based software improves radiologist detection of malignant lung nodules on chest radiographs

Central focused convolutional neural networks: developing data-driven model for lung nodule segmentation

Semi-supervised adversarial model for benign-malignant lung nodule classification on chest CT

Multi-task deep model with margin ranking loss for lung nodule analysis

Artificial intelligence-enabled rapid diagnosis of patients with COVID-19

AI augmentation of radiologist performance in distinguishing COVID-19 from pneumonia of other

Initial chest radiographs and artificial intelligence (AI) predict clinical outcomes in COVID-19 patients: analysis of 697 Italian patients

COVIDiag: a clinical CAD system to diagnose COVID-19 pneumonia based on CT findings

Artificial intelligence distinguishes COVID-19 from community acquired pneumonia on chest CT

Encoder-decoder with atrous separable convolution for semantic image segmentation

Deep residual learning for image recognition

Atrous convolution for binary semantic segmentation of lung nodule

DeepLab: semantic image segmentation with deep convolutional nets, atrous convolution, and fully connected CRFs

Learning spatio-temporal features with 3D residual networks for action recognition

Predicting time series with support vector machines

Random forest: a classification and regression tool for compound classification and QSAR modeling

Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients

Diagnostic efficacy of anti-SARS-CoV-2 IgG/IgM test for COVID-19: a meta-analysis

Evolution of CT findings in patients with mild COVID-19 pneumonia

A deep learning approach to characterize 2019 coronavirus disease (COVID-19) pneumonia in chest CT images

Ultra-low-dose chest CT imaging of COVID-19 patients using a deep residual neural network

Automated quantification of COVID-19 severity and progression using chest CT images

COVID-19, AI enthusiasts, and toy datasets: radiology without radiologists

Learning to detect pathogenic microorganism of community-acquired pneumonia

From communityacquired pneumonia to COVID-19: a deep learning-based method for quantitative analysis of COVID-19 on thicksection CT scans

Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

Acknowledgements The authors would like to thank the radiologist teams from Tongji Hospital, Institute of Basic Medicine and Cancer (IBMC) of Chinese Academy of Sciences, Huangpi People's Hospital and Zhejiang Provincial People's Hospital for their hard works. We appreciate the valuable suggestions given by Dr. Xue-Qin Zhou from Swiss Federal Institute of Technology Zurich and Shanghai Soundwise Healthcare Co. Ltd.